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Abstract
Squamous cell carcinoma (SCC) of the rectum is a rare malignancy, and the optimal treatment strategy remains unknown. Cases are limited in the literature, and although historically treated with surgical resection, more recent cases
have suggested success with chemotherapy. Although Nigro protocol was initially developed for anal SCC, we present a
case of rectal SCC successfully treated with the Nigro protocol. Our case supports the use of chemoradiotherapy as initial
treatment for rectal SCC over surgery.
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1. Introduction

C

olorectal cancer is currently one of the leading
causes of cancer-related deaths among men
and women in the United States. Although adenocarcinoma comprises 95% of colorectal cancers,
squamous cell carcinoma (SCC) is extremely uncommon, accounting for less than 1% of total cases.1
SCC can be occasionally seen in the upper aerodigestive tract and anal canal, but SCC of the rectum
is a rare malignancy.1 Given this infrequent incidence, the optimal treatment strategy for rectal SCC
has yet to be determined, and cases describing
various approaches remain limited in the literature.
Historically, the vast majority of localized rectal SCC
has been treated at diagnosis with primary surgical
resection, which has known long-term treatmentrelated morbidities. More recent cases in the literature, however, have been noted to have successful
outcomes with chemotherapy regimens. Although
the Nigro protocol was initially developed for anal
SCC, we present a case of rectal SCC successfully
treated with the Nigro protocol rather than traditional surgical resection. Our case supports the use
of chemoradiotherapy via the Nigro protocol as an
initial treatment for rectal SCC over more aggressive interventions such as surgery.

2. Case report
A 74-year-old man with no signiﬁcant past medical
history presented to his primary care physician for a
routine visit. He was found to have new-onset
microscopic hematuria. As part of workup, he underwent a CT abdomen/pelvis which showed an
incidental ﬁnding of a 4.8 cm mass arising from the
right mid-rectal wall (Fig. 1A). He was asymptomatic
with no changes in bowel habits including constipation, diarrhea or hematochezia. He had undergone a routine surveillance colonoscopy 2 years prior
which was unremarkable. To evaluate the rectal
mass, a colonoscopy was performed which revealed
erythematous nodular friable mucosa located in the
proximal rectum about 13 cm from the anal verge,
with normal intervening mucosa between the anal
canal and the lesion (Fig. 2). Biopsy results revealed a
diagnosis of SCC (Fig. 3). The patient had no evidence
or symptoms to suggest an alternate primary malignancy. A PET CT was subsequently performed,
which was consistent with a primary rectal malignancy without distant metastases. After multidisciplinary discussions with colorectal surgery and
oncology, due to the relatively distal location of the
mass, a decision was made to treat the patient with
Nigro protocol chemoradiotherapy rather than
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Fig. 1. (A) CT imaging demonstrating right rectal wall mass measuring 4.8 cm AP x 4.1 cm transverse; (B) CT imaging 3 months later demonstrating
marked decrease in tumor size to a soft tissue rectal wall prominence.

primary surgical resection. Patient underwent radiation and chemotherapy via the Nigro protocol.
Follow-up imaging 3 months later showed a marked
decrease in tumor size down to a residual soft tissue
prominence (Fig. 1B). He currently remains on active
surveillance with serial PET CT scans every 6 months.

Fig. 2. Endoscopy image demonstrating erythematous nodular friable
mass in the rectum.

Fig. 3. H&E stain (10x) showing SCC on the surface and columnar
colorectal mucosa (crypts) in the lamina.

3. Discussion
Rectal SCC is a rare primary gastrointestinal
malignancy, with an incidence of 0.1/1000 cases of
colorectal cancer.1 When SCC involves the rectum,
it is more commonly due to extension from primary anal SCC, which typically presents as a
contiguous lesion. Our case, however, had normal
intervening rectal mucosa between the anal mucosa and the mass. Initially reported in 1933, rectal
SCC has since mostly been described in case reports and case series.2 Typical symptoms have
been reported to include rectal bleeding or altered
bowel habits, however, our patient was unusually
asymptomatic. Diagnosis is typically established
by endoscopic biopsy. Most cases of rectal SCC
are localized and early-stage at diagnosis. After
tissue diagnosis, a PET scan can be helpful in
ruling out an alternative primary squamous cell
cancer.
Although the ﬁrst case of rectal SCC was reported
in the early 20th century, the pathogenesis has still
not been well-established, though multiple theories
have been proposed. The leading theory remains
the metaplasia-dysplasia-carcinoma sequence.3
Histologically, the squamous epithelium of the anal
canal is adjacent to the columnar epithelium of the
rectum. Repeated irritative and inﬂammatory
changes of the mucosa can lead to metaplastic
changes which occur naturally due to a reversible
adaptive mechanism to withstand particular insults.
These changes can progress stepwise into dysplasia
and subsequently carcinoma. In addition to this,
pluripotent stem cells, which are capable of multidirectional cellular differentiation under injurious
conditions, have also been implicated in the development of rectal SCC.4 Lastly, although there is no
proven pathophysiologic mechanism of HPV leading to rectal SCC, there has been an association with
increased incidence of HPV markers including p16
in patients with rectal SCC.5

Traditionally, the treatment for rectal SCC has
consisted primarily of surgical intervention with
anterior resection (AR) or abdominal perineal
resection (APR). Over the past few years, however, in
part due to the various long term treatment-related
morbidities associated with these invasive surgeries,
there has been increasing interest in development of
less invasive treatment regimens for rectal SCC.4,8e10
On review of literature, there are several prospective
studies evaluating the role of chemoradiotherapy as
the primary therapy. In the mid-1970s, the Nigro
protocol, consisting of radiation therapy combined
with 5-ﬂuorouracil and mitomycin, was developed
for anal cancer where it has been used for decades
with success.6 In limited cases, this protocol has
suggested promise in treatment of rectal SCC with
favorable overall survival results as well as the
beneﬁt of sphincter preservation when compared to
surgical intervention.7,10 Due to this, we opted to
treat our patient with the Nigro protocol and had a
successful outcome. Despite treatment success, it is
important to note the complications of chemoradiotherapy including stricture, ﬁstula, perforation
and radiation proctitis. Ongoing research into the
optimal treatment of this rare malignancy, however,
is needed and we encourage reporting of future cases
of rectal SCC to help distinguish which patients may
be better suited for chemoradiotherapy regimens
over traditional surgical intervention.
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